Health and Happiness (H&H) International Holdings (8BI) Stock Statistics & Valuation Metrics
Total Valuation
Health and Happiness (H&H) International Holdings has a market cap or net worth of EUR 1.76B. The enterprise value is EUR 13.15B.
- Market Cap
- EUR 1.76B
- Enterprise Value
- EUR 13.15B
Share Statistics
Health and Happiness (H&H) International Holdings has 645,561,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 645,561,340
- Owned by Insiders
- ―
- Owned by Institutions
- 3.80%
Financial Efficiency
Health and Happiness (H&H) International Holdings’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 3.66%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 3.66%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 5.20M
- Profits Per Employee
- 71.12K
- Employee Count
- 2,758
- Asset Turnover
- 0.74
- Inventory Turnover
- 2.74
Valuation Ratios
The current PE Ratio of Health and Happiness (H&H) International Holdings is 17.79. Health and Happiness (H&H) International Holdings’s PEG ratio is 0.02.
- PE Ratio
- 17.79
- PS Ratio
- 0.82
- PB Ratio
- 2.02
- Price to FCF
- 8.17
- Price to Operating Cash Flow
- 7.87
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Health and Happiness (H&H) International Holdings had revenue of 14.35B and earned 196.14M in profits. Earnings per share was 0.31.
- Revenue
- 14.35B
- Gross Profit
- 8.96B
- Operating Income
- 1.67B
- Pretax Income
- 563.10M
- Net Income
- 196.14M
- EBITDA
- 1.87B
- Earnings Per Share (EPS)
- 0.31
Cash Flow
In the last 12 months, operating cash flow was 1.67B and capital expenditures -52.29M, giving a free cash flow of 1.62B billion.
- Operating Cash Flow
- 1.67B
- Free Cash Flow
- 1.62B
- Free Cash Flow per Share
- 2.52
Dividends & Yields
Health and Happiness (H&H) International Holdings pays an annual dividend of ―, resulting in a dividend yield of 6.17%
- Dividend Per Share
- ―
- Dividend Yield
- 6.17%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 12.24%
- Earnings Yield
- 5.60%
Stock Price Statistics
- Beta
- 0.47
- 52-Week Price Change
- 109.30%
- 50-Day Moving Average
- 2.10
- 200-Day Moving Average
- 1.55
- Relative Strength Index (RSI)
- 72.33
- Average Volume (3m)
- 354
Important Dates
Health and Happiness (H&H) International Holdings upcoming earnings date is Mar 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 25, 2026
- Next Earnings Date
- Mar 23, 2027
- Ex-Dividend Date
- ―
Financial Position
Health and Happiness (H&H) International Holdings as a current ratio of 1.15, with Debt / Equity ratio of 151.11%
- Current Ratio
- 1.15
- Quick Ratio
- 0.72
- Debt to Market Cap
- 1.18
- Net Debt to EBITDA
- 3.94
- Interest Coverage Ratio
- 2.44
Taxes
In the past 12 months, Health and Happiness (H&H) International Holdings has paid 366.96M in taxes.
- Income Tax
- 366.96M
- Effective Tax Rate
- 0.65
Enterprise Valuation
Health and Happiness (H&H) International Holdings EV to EBITDA ratio is 7.07, with an EV/FCF ratio of 11.78.
- EV to Sales
- 1.19
- EV to EBITDA
- 7.07
- EV to Free Cash Flow
- 11.78
- EV to Operating Cash Flow
- 11.42
Balance Sheet
Health and Happiness (H&H) International Holdings has EUR 1.99B in cash and marketable securities with EUR 7.72B in debt, giving a net cash position of -EUR 5.73B billion.
- Cash & Marketable Securities
- EUR 1.99B
- Total Debt
- EUR 7.72B
- Net Cash
- -EUR 5.73B
- Net Cash Per Share
- -EUR 8.87
- Tangible Book Value Per Share
- -EUR 9.24
Margins
Gross margin is 64.01%, with operating margin of 15.47%, and net profit margin of 4.59%.
- Gross Margin
- 64.01%
- Operating Margin
- 15.47%
- Pretax Margin
- 8.64%
- Net Profit Margin
- 4.59%
- EBITDA Margin
- 16.81%
- EBIT Margin
- 14.89%
Analyst Forecast
The average price target for Health and Happiness (H&H) International Holdings is EUR 3.19, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 3.19
- Price Target Upside
- 18.18% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 10
- Revenue Growth Forecast
- 15.52%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 10
- AI Score
- ―
